Literature DB >> 25482178

Brain biomarkers of treatment for multi-domain dysfunction: pharmacological FMRI studies in pediatric mania.

Mani Pavuluri1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25482178      PMCID: PMC4262909          DOI: 10.1038/npp.2014.229

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  5 in total

1.  Amygdala functional connectivity predicts pharmacotherapy outcome in pediatric bipolar disorder.

Authors:  Ezra Wegbreit; James A Ellis; Aneesh Nandam; Jacklynn M Fitzgerald; Alessandra M Passarotti; Mani N Pavuluri; Michael C Stevens
Journal:  Brain Connect       Date:  2011-12-07

Review 2.  Emerging biosignature of brain function and intervention in pediatric bipolar disorder.

Authors:  T Mayanil; E Wegbreit; J Fitzgerald; M Pavuluri
Journal:  Minerva Pediatr       Date:  2011-06       Impact factor: 1.312

3.  Neurocognitive function in pediatric bipolar disorder: 3-year follow-up shows cognitive development lagging behind healthy youths.

Authors:  Mani N Pavuluri; Amy West; S Kristian Hill; Kittu Jindal; John A Sweeney
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-03       Impact factor: 8.829

4.  A preliminary functional magnetic resonance imaging study of prefrontal-amygdalar activation changes in adolescents with bipolar depression treated with lamotrigine.

Authors:  Kiki D Chang; Christopher Wagner; Amy Garrett; Meghan Howe; Allan Reiss
Journal:  Bipolar Disord       Date:  2008-05       Impact factor: 6.744

5.  Time course of recovery showing initial prefrontal cortex changes at 16 weeks, extending to subcortical changes by 3 years in pediatric bipolar disorder.

Authors:  Hongyu Yang; Lisa H Lu; Minjie Wu; Michael Stevens; Ezra Wegbreit; Jacklynn Fitzgerald; Bryn Levitan; Stewart Shankman; Mani N Pavuluri
Journal:  J Affect Disord       Date:  2013-03-18       Impact factor: 4.839

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.